Pharmacogenomic insights into treatment and management of statin-induced myopathy

Although statins are generally well tolerated, the most common adverse drug reaction from statin therapy is myopathy. This article reviews the current pharmacogenomic knowledge of statin-induced myopathy. Furthermore, we will discuss the importance of recent pharmacogenetic advances for the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Bas JM, Klungel, Olaf H, Visseren, Frank L, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808736/
https://www.ncbi.nlm.nih.gov/pubmed/20090898
http://dx.doi.org/10.1186/gm120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808736/
https://www.ncbi.nlm.nih.gov/pubmed/20090898
http://dx.doi.org/10.1186/gm120

Ejemplares similares